NAFLD Associated Comorbidity-Reference-Cited by-同舟云学术

NAFLD Associated Comorbidity

Published:2021-12-23 Issue:10 Volume: Page:5-13
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:jour

Author:

Lazebnik L. B.¹^ORCID,Turkina S. V.²^ORCID

Affiliation:

1. A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russion Federation

2. Volgograd State Medical University of the Ministry of Public Health of the Russian Federation

Abstract

Non-alcoholic fatty liver disease (NAFLD) is considered not only as a disease with poor hepatic prognosis. The problem has acquired a multidisciplinary problem. The variety of concomitant diseases and pathological conditions are united by common pathophysiological mechanisms.This review summarizes and presents the data available in the modern literature on the association of NAFLD with cardiovascular diseases, type 2 diabetes mellitus, polycystic ovary syndrome, chronic kidney disease, etc. The role of the liver in the homeostasis of the organism and the pathogenetic mechanisms of the formation of NAFLD-associated comorbidity are discussed.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference87 articles.

1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. doi: 10.1002/hep.28431. PMID: 26707365.

2. Younossi Z., Anstee Q., Marietti M. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018; 15: 11-20 doi: 10.1038/nrgastro.2017.109.

3. Drapkina O., Evsyutina Y., Ivashkin V. Prevalence of non-alcoholic fatty liver disease in the Russian Federation: the open, multicenter, prospective study, DIREG 1. American Journal of Clinical Medicine Research. 2015; 3 (2): 31-36.

4. Drapkina O. M., Ivashkin V. T. Liver disease structure explored in Russian Federation: national-wide DIREG-L-01903 study for non-alcoholic fatty liver disease screening. Journal of Hepatology. 2011; 54: 332.

5. Ivashkin V. T., Drapkina O. M., Maev I. V., Trukhma-nov A. S., et al. Liver disease in patients of outpatient practice in the Russian Federation: results of the DIREG 2 study. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2015; 6: 31-41. (in Russ.)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insomnia as a disorder of the circadian rhythm of the brain and gut;Meditsinskaya sestra;2024-07-19

2. NAFLD is a predictor of high risk of development and a co-factor in the progression of cardiovascular diseases;South Russian Journal of Therapeutic Practice;2024-06-24

3. Metabolic-associated fatty liver disease and older age;Experimental and Clinical Gastroenterology;2024-03-19

4. DIAGNOSTIC VALUE OF NITROGEN METABOLISM DISORDERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN COMORBID PATIENTS WITH METABOLIC SYNDROME AND STRATIFICATION OF DISEASE STAGES;Ulyanovsk Medico-biological Journal;2023-09-29

5. Development of a comorbidity phenotype of acid-dependent diseases and arterial hypertension syndrome for a personalized approach to diagnosis and treatment;Experimental and Clinical Gastroenterology;2023-07-25